Organized by the Students for Sensible Drug Policy with the support of Youth RISE Since the beginning of 2020, the world has been experiencing an unprecedented public health emergency, which has led to a dramatic shift in how young people live. The pandemic bore major consequences on how young people are experiencing their everyday and …
Organized the UNODC Drug Research Section Moderated by: Ms Chloé Carpentier, Chief, Drug Research Section, UNODC Research and Trend Analysis Branch (Missed initial 2 minutes) Mr Antoine Vella, Research Officer (Cocaine), Drug Research Section, UNODC Research and Trend Analysis Branch: …to mimic the processes in Colombia sometimes with the involvement of Colombian nationals and also …
Moderator: This is the side event on the impact of COVID on drug markets, one year later. COVID has really changed our lives and also the way we’re working. It has resulted in actually more work because in addition to our normal research, we are also conducting research on how COVID impacts the drug and …
Valerie Chiang: Today many of the community of joined Singapore’s program to rehabilitate and reintegration. Our goal is for every inmate to have social support by the time they are released. The Yellow Ribbon project is a grassroots project, offering emotional support and support in the community. Over 5000 employers registered to offer opportunities for …
Chair: Good Morning Delegates. We will resume on item 5 (a) Secretariat: documents have been prepared under 5(a).. available now on commission’s website Chair: Proceed to WHO scheduling recommendations on substances under 1961 and 1971 Convention communicated after 63rd meeting of Expert Committee on Drug Dependence. We will now vote on isotonitazene to add to schedule I …
Side Event: Protecting civil society space at times of COVID-19: Lessons learned for advocacy Organized by the Youth Organisations for Drug Action (YODA) with the support of Australia, Canada, Mexico and Switzerland, and the Centre on Drug Policy Evaluation, Frontline AIDS, and the International Drug Policy Consortium In March 2020, the World Health Organization characterised …